These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25560589)

  • 1. The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain.
    Roczniak W; Babuśka-Roczniak M; Kwapuliński J; Brodziak-Dopierała B; Widuchowski W; Cipora E; Nowak P; Oświęcimska JM
    Pharmacol Rep; 2015 Feb; 67(1):146-51. PubMed ID: 25560589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of dopamine (DA) synthesis rate in selected parts of the rat brain with central noradrenergic lesion after administration of 5-HT3 receptor ligands.
    Roczniak W
    Postepy Hig Med Dosw (Online); 2013 Jul; 67():648-52. PubMed ID: 24018429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of central noradrenergic system lesion on the serotoninergic 5-HT3 receptor mediated analgesia in rats.
    Roczniak W; Wróbel J; Dolczak L; Nowak P
    Adv Clin Exp Med; 2013; 22(5):629-38. PubMed ID: 24285447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum.
    Porras G; De Deurwaerdère P; Moison D; Spampinato U
    Eur J Neurosci; 2003 Feb; 17(4):771-81. PubMed ID: 12603267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the analgesic effect of morphine on models of acute nociceptive pain in rats with a central noradrenergic system lesion.
    Roczniak W; Oswiecimska JM; Brodziak-Dopierala B; Cipora E; Nowak PG; Babuska-Roczniak M
    Neuro Endocrinol Lett; 2016 Jul; 37(3):239-244. PubMed ID: 27618597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple opioid receptors mediate the hypotensive response induced by central 5-HT(3) receptor stimulation.
    Fregoneze JB; Oliveira EF; Ribeiro VF; Ferreira HS; De Castro E Silva E
    Neuropeptides; 2011 Jun; 45(3):219-27. PubMed ID: 21514668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
    Riga MS; Sánchez C; Celada P; Artigas F
    Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.
    Higgins GA; Joharchi N; Sellers EM
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1440-9. PubMed ID: 8450478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of in vivo hydroxylation of tyrosine and tryptophan in rat striatum by microdialysis-HPLC: relationship between dopamine and serotonin biosynthesis.
    Hashiguti H; Nakahara D; Maruyama W; Naoi M; Ikeda T
    J Neural Transm Gen Sect; 1993; 93(3):213-23. PubMed ID: 7692885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional amygdaloid control of neuropathic hypersensitivity mediated by descending serotonergic pathways acting on spinal 5-HT3 and 5-HT1A receptors.
    Sagalajev B; Bourbia N; Beloushko E; Wei H; Pertovaara A
    Behav Brain Res; 2015 Apr; 282():14-24. PubMed ID: 25557801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflurane inhibits bronchopulmonary C-fiber-mediated apneic response to phenylbiguanide by depressing 5-HT3 receptor function in anesthetized rats.
    Zhang Z; Zhuang J; Zhang C; Xu F
    Neurosci Lett; 2013 Sep; 552():1-4. PubMed ID: 23896531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: a microdissection mapping study.
    Baumann MH; Raley TJ; Partilla JS; Rothman RB
    Synapse; 1993 May; 14(1):40-50. PubMed ID: 8511717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HT(1A) receptors modulating serotonin and dopamine synthesis in rat brain in vivo.
    Esteban S; Moranta D; Sastre-Coll A; Miralles A; García-Sevilla JA
    Neurosci Lett; 2002 Jun; 326(2):121-4. PubMed ID: 12057843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.
    Zazpe A; Artaiz I; Del Río J
    Br J Pharmacol; 1994 Nov; 113(3):968-72. PubMed ID: 7858893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain.
    Moranta D; Esteban S; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):61-72. PubMed ID: 18709357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal co-lesion by DSP-4 and 5,7-DHT produces adulthood behavioral sensitization to dopamine D(2) receptor agonists.
    Nowak P; Nitka D; Kwieciński A; Jośko J; Drab J; Pojda-Wilczek D; Kasperski J; Kostrzewa RM; Brus R
    Pharmacol Rep; 2009; 61(2):311-8. PubMed ID: 19443944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B
    Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of c-Fos expression in the central nervous system of mice following right atrial injections of the 5-HT3 receptor agonist phenylbiguanide.
    de Vries A; Paton JF; Lightman SL; Lowry CA
    Auton Neurosci; 2005 Dec; 123(1-2):62-75. PubMed ID: 16298172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep Deprivation-Induced Blood-Brain Barrier Breakdown and Brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles. Neuroprotective Effects of a 5-HT3 Receptor Antagonist Ondansetron.
    Sharma A; Muresanu DF; Lafuente JV; Patnaik R; Tian ZR; Buzoianu AD; Sharma HS
    Mol Neurobiol; 2015 Oct; 52(2):867-81. PubMed ID: 26133300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breathing stimulation mediated by 5-HT
    Iovino L; Mutolo D; Cinelli E; Contini M; Pantaleo T; Bongianni F
    Brain Res; 2019 Feb; 1704():26-39. PubMed ID: 30244021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.